Moreover, the level of Cx26 was markedly higher in gefitinib-insensitive NSCLC cell lines (A549 and H1299) than that in gefitinib-sensitive NSCLC cell lines (HCC827 and PC9). The gene discussed is GJB2; the disease is non-small cell lung carcinoma.